These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27623226)

  • 1. [Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome].
    Menéndez Valladares P; Arrobas Velilla T; Bermúdez de la Vega JA; Romero Pérez MD; Fabiani Romero F; González Rodríguez C
    Clin Investig Arterioscler; 2016; 28(5):227-229. PubMed ID: 27623226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia and nephrotic syndrome: recent advances.
    Kronenberg F
    J Ren Nutr; 2005 Apr; 15(2):195-203. PubMed ID: 15827892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
    Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.
    Yang X; Wang H; Zhu Z; Deng A
    J Tongji Med Univ; 1998; 18(4):236-8. PubMed ID: 10806854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD; Azrolan N; Thomas L; Roberts KG; Bostom A; Zhao ZH; Friedman EA
    Am J Kidney Dis; 1995 Jul; 26(1):170-7. PubMed ID: 7611249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C; Doucet C; Baumelou A; Chapman J; Jacobs C; Thillet J
    Am J Kidney Dis; 1993 Dec; 22(6):808-13. PubMed ID: 8250027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators--A pilot study.
    Kucera M; Balaz D; Kruzliak P; Ciccocioppo R; Oravec S; Rodrigo L; Zulli A; Hirnerova E; Sabaka P; Komornikova A; Sabo J; Slezak P; Gaspar L
    Clin Biochem; 2015 Jun; 48(9):557-61. PubMed ID: 25727667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
    Hari P; Khandelwal P; Smoyer WE
    Pediatr Nephrol; 2020 Sep; 35(9):1601-1619. PubMed ID: 31302760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.